FreeIn the Archives Breaking barriers: women in oncology, learning from survivors, and keen-eyed pioneers May 14, 2021Vol.47 No.19
FreeGuest Editorial Menthol ban has been a no-brainer for decades—will it finally happen? May 07, 2021Vol.47 No.18By Phoenix A. Matthews and Robert A. Winn
FreeGuest Editorial The unKOOL, unfiltered history of menthol cigarettes May 07, 2021Vol.47 No.18By Alan Blum
Free CTCA leaves Tulsa and Philadelphia; Tulsa move comes amid Blue Cross cost-cutting moves May 07, 2021Vol.47 No.18By Paul Goldberg
Conversation with The Cancer LetterFree Hinrichs reflects on his move from NCI to Rutgers Cancer Immunology and Metabolism Center of Excellence May 07, 2021Vol.47 No.18By Paul Goldberg
Cancer History ProjectFree A document in perspective: Otis Brawley on Frank J. Rauscher’s 1975 Cancer Program update May 07, 2021Vol.47 No.18By Otis W. Brawley and Paul Goldberg
FreeIn the Archives Answering big questions: Beatrice Mintz, Donald Pinkel, Baruch Blumberg, Irwin Rose May 07, 2021Vol.47 No.18
In 3-day marathon, ODAC winnows “dangling” accelerated approvals of PD-1/PD-L1 drugs April 30, 2021Vol.47 No.17By Paul Goldberg
Conversation with The Cancer LetterFree We ask FDA to explain “dangling” accelerated approvals—and this week’s ODAC agenda April 30, 2021Vol.47 No.17By Paul Goldberg
Biden urges Congress to fund ARPA-H as OSTP nominee Eric Lander defines agency’s mission April 30, 2021Vol.47 No.17By Matthew Bin Han Ong
